Serinus Biosciences
New accelerator entry · 2022-06-28 · the record
In their words
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Serinus Biosciences
- Source Check — verify what Serinus Biosciences states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Serinus Biosciences for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Serinus BiosciencesYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Serinus Biosciences: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.